首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1671842

合约临床研究组织市场：按服务类型、临床监测、治疗领域、最终用户和地区划分

Contract Clinical Research Organization Market, By Service Type, Clinical Monitoring, By Therapeutic Area, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球合约临床研究组织市场规模预计为 877.1 亿美元，预计到 2032 年将达到 1,655.6 亿美元，2025 年至 2032 年的复合年增长率为 9.5%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	877.1亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	9.50％	2032 年价值预测	1655.6亿美元

数字。 2025 年合约临床研究组织市场占有率（按地区）

过去几年，全球合约临床研究组织（CRO）市场一直稳定成长。 CRO 是透过提供外包研究服务来支援製药、生技和医疗设备业的公司。我们提供临床试验设计、资料管理、生物统计分析、监管服务等。药物发现和研发过程的演变增加了製药公司的研究的复杂性和成本，迫使他们将研究活动外包。此外，药物开发週期的缩短也推动了对拥有跨各个治疗领域专业知识和基础设施的外部服务供应商的需求。这些因素极大地推动了合约临床研究组织市场的成长。

市场动态：

製药公司不断增加的研发支出和日益采用外包策略正在极大地推动全球合约临床研究组织市场的发展。此外，对专业临床试验服务的需求不断增长以及先进技术的快速发展正在为该市场创造新的机会。然而，严格的法规和延迟的核准时间带来了重大挑战。此外，知识产权（IP）和资料安全相关的风险也在一定程度上抑制了市场的成长。製药公司目前正在采用 CRO 的创新交付模式，以品质、专业知识和先进技术为驱动力，以获得竞争优势。预计这将在未来几年开闢新的途径。

本研究的主要特点

本报告对全球合约临床研究组织市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。

该报告根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，提供了全球合约临床研究组织 (CRO) 市场主要企业的概况。

研究涉及的主要公司包括 IQVIA、Covance、Syneos Health、PPD（Pharmaceutical Product Development）、ICON plc、Charles River Laboratories、Medpace、Parexel International、WuXi AppTec、PRA Health Sciences、KCR、Celerion、Catalent、BioClinica 和 Clinicace。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球合约临床研究组织市场的各种策略矩阵来简化决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 87.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.50%	2032 Value Projection:	US$ 165.56 Bn

The global contract clinical research organization market has been witnessing steady growth over the past few years. CROs are companies that support the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. They provide clinical trial design, data management, biostatistical analysis, regulatory affairs services, and other services. The evolution of drug discovery and development processes has increased research complexities and costs for pharmaceutical companies, compelling them to outsource their research activities. Moreover, abbreviated drug development cycles have increased the demand for external service providers having expertise and infrastructure across varied therapeutic areas. These factors have boosted the contract clinical research organization market growth significantly.

Market Dynamics:

Rising research and development (R&D) expenditure of pharmaceutical companies along with higher adoption of outsourcing as a strategy is significantly driving the global contract clinical research organization market. Moreover, increasing demand for specialized clinical trial services and rapid evolution of advanced technologies are creating new opportunities in this market. However, stringent regulations and slower approval timelines pose major challenges. Additionally, the intellectual property (IP) rights and data security related risks restrain market growth to some extent. Pharmaceutical companies are now adopting innovative delivery models from CROs driven by quality, expertise, and advanced technologies to gain competitive advantage. This is expected to open up new avenues over the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global contract clinical research organization market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global contract clinical research organization (CRO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Covance, Syneos Health, PPD (Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, and Clinipace

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global contract clinical research organization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract clinical research organization market

Market Segmentation

Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Clinical Trial Service
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Other Therapeutic Areas
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Research & Academic Institutions
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- IQVIA
- Covance
- Syneos Health
- PPD (Pharmaceutical Product Development)
- ICON plc
- Charles River Laboratories
- Medpace
- Parexel International
- WuXi AppTec
- PRA Health Sciences
- KCR
- Celerion
- Catalent
- BioClinica
- Clinipace

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Contract Clinical Research Organization Market, By Service Type
- Global Contract Clinical Research Organization Market, By Therapeutic Area
- Global Contract Clinical Research Organization Market, By End User
- Global Contract Clinical Research Organization Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Contract Clinical Research Organization Market, By Service Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Clinical Trial Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase III
- Phase II
- Phase I
- Phase IV
Clinical Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Site Monitoring
- Data Monitoring
Early phase development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analytical Testing Services
- Bioanalytical Testing Services
Regulatory Affairs Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contract Clinical Research Organization Market, By Therapeutic Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contract Clinical Research Organization Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research & Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Clinical Research Organization Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Pharmaceutical Product Development)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PRA Health Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Celerion
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent
BioClinica
Clinipace

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

合约临床研究组织市场：按服务类型、临床监测、治疗领域、最终用户和地区划分